Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Chong Kun Dang Pharmaceutical"
Count: 252
Selected: 0
| NCT ID | Title |
|---|
| NCT05050604 | A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients | ||
| NCT05041790 | A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment | ||
| NCT04746287 | Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects | ||
| NCT05347576 | A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions | ||
| NCT05335044 | Phase 1 Study to Evaluate the Safety and Pharmacokinetics of CKD-331 in Healthy Adult Volunteers | ||
| NCT04805606 | A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 | ||
| NCT05274880 | Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393 | ||
| NCT04488900 | Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects | ||
| NCT05245084 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg | ||
| NCT05238948 | CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects | ||
| NCT04987970 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg | ||
| NCT05193565 | Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients | ||
| NCT05207761 | Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930 | ||
| NCT05192356 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3) | ||
| NCT05189288 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects | ||
| NCT05089279 | Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers | ||
| NCT05113693 | A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393 in Healthy Volunteers Under Fed Conditions | ||
| NCT05108038 | A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects | ||
| NCT05043467 | Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus | ||
| NCT04869800 | Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg | ||
| NCT03739125 | Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes | ||
| NCT04830930 | A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers | ||
| NCT04628143 | A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | ||
| NCT04871646 | Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 | ||
| NCT04768673 | A Study to Investigate the PK and Safety of CKD-393 | ||
| NCT04539652 | Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients | ||
| NCT04312698 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-386 | ||
| NCT03794492 | Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome | ||
| NCT04952506 | Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers | ||
| NCT04694989 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) | ||
| NCT04673864 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386 | ||
| NCT04255589 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 | ||
| NCT04810676 | A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383. | ||
| NCT04548427 | Study to Evaluate the Efficacy and Safety of CKD-352 | ||
| NCT04906798 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions | ||
| NCT04906785 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions | ||
| NCT04883658 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) | ||
| NCT04867720 | Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients | ||
| NCT04867200 | A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers | ||
| NCT04260438 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects | ||
| NCT04857177 | A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration | ||
| NCT04840745 | The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1 | ||
| NCT04587206 | A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 | ||
| NCT04623021 | A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia | ||
| NCT04706286 | Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393 | ||
| NCT04703374 | A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects | ||
| NCT04700709 | Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. | ||
| NCT03749356 | Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients | ||
| NCT04678388 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions | ||
| NCT04676893 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects |
